Initial resistance to companion drugs should not be considered an exclusion criterion for the shorter multidrug-resistant tuberculosis treatment regimen

OBJECTIVES: We investigated whether companion drug resistance was associated with adverse outcomes of the shorter multidrug-resistant tuberculosis (MDR-TB) treatment regimen in Bangladesh after adjustment for fluoroquinolone resistance. METHODS: MDR-TB/rifampicin-resistant tuberculosis patients regi...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Int J Infect Dis
Main Authors: Lempens, Pauline, Decroo, Tom, Aung, Kya J.M., Hossain, Mohammad A., Rigouts, Leen, Meehan, Conor J., Van Deun, Armand, de Jong, Bouke C.
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2020
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7670168/
https://ncbi.nlm.nih.gov/pubmed/32829049
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijid.2020.08.042
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki